The layout of the chapters is predictable, with the first chapter describing basic renal structure and physiology in classic textbook style. Chapter 2 covers the various methods for measuring urinary albumin in terms of both assays and types of urinary collection. Methods for screening for microalbuminuria are pertinent to all physicians caring for patients with diabetes and thus the figure depicting a scheme for screening is rather disappointing in its lack of detail, especially since specific screening guidelines exist in England and Scotland. The chapter on epidemiology I found particularly interesting as the authors review the data on urinary albumin in normal man, provide their definitions of microalbuminuria (albumin:creatinine ratio > 1.43 mg/mmol in males and > 1.80 mg/mmol in females) and highlight the association with blood pressure. The chapter that covers microalbuminuria in diabetes is admirably comprehensive especially in the collation of all the studies in type 1 and type 2 diabetes that estimate the prevalence of microalbuminuria, given that the definition of microalbuminuria is not the same in all studies. One problem when distilling so much data from studies with differing designs is knowing how to present the summary data. The tabular format selected by the authors is not entirely successful.
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No self-respecting book on vascular pathophysiology can be complete without a reasonable section on nitric oxide and other endothelial dilating and contracting factors, coagulation, fibrinolysis and endothelial function, and a chapter on this theme provides a bridge into a section on microalbuminuria and cardiovascular disease. This association is particularly important since cardiovascular disease is the principal cause ofdeath in diabetes and also accounts for much morbidity. The chapter details the clustering of adverse vascular factors with microalbuminuria. A short chapter on microalbuminuria as a non-specific marker of disease precedes the final chapter, of particular interest to practising clinicians since it discusses the management of microalbuminuria. The major interventions glycaemic control, blood pressure modulation with or without ACE inhibition, and dietary protein restriction are dealt with in depth and mention is made of less well tested interventions such as aldose reductase inhibitors, heparin and lipid-lowering agents. This is a well-written and thoroughly researched book with some up-to-the-minute results on genetic factors added at the proof stage. The writing style is easy and it is clear that the authors are practising clinicians with the patient sharply in focus. The tables and figures are a little disappointing but the text makes up for this. This volume should be in all hospital libraries, and physicians with an interest in diabetes will find it an excellent resource from which to decide their own evidence-based screening and treatment protocols. Elsie Inglis' death in 1917, less than a year before the end of the Great War, was marked by an unprecedented display of national grief: Queen Mary sent condolences to the family, crowds lined Princes Street to watch the coffin pass, the body lay in state in St Giles Cathedral, and a crowded memorial service at Westminster Abbey was attended by establishment figures, envoys and dignitaries. The large congregation was there to honour, in the words of the Bishop of Oxford, a 'truly glorious woman' . . . who 'exhibited in the highest degree a combination of personal self-sacrifice and tenderest sympathy, with a rare capacity for origination and government'.
The object of his eulogy is largely forgotten today. Elsie Inglis spent most of her life working tirelessly but inconspicuously for improved medical services for women and children in Edinburgh. Hardly the stuff of which national heroines are made. In 1914, however, at the age of 50, she set up the Scottish Women's Hospitals for Foreign Service (SWH), an organization that aimed to provide medical services at the Front, run and staffed entirely by women. Under its auspices over a thousand women-doctors, nurses and support staff were sent abroad to tend the casualties in field hospitals. As Leah Leneman shows in her interesting biography, Elsie Inglis' death aroused such a public reaction entirely because of her work with the SWH, carried out during the last three years of her life. And indeed her achievements in that short time were remarkable. Inglis qualified in medicine in Scotland in 1892. A spell in London at Elizabeth Garrett Anderson's New Hospital for Women opened her eyes to the lot of the working class women and awakened an interest in the Suffrage movement. She became an active member of an Edinburgh group on her return to Scotland, and opened a small hospital for women in 1899. The refusal by the War Office and RAMC to take up offers of help from women doctors at the outbreak of World War I goaded Inglis into action; in September 1914 the formation of the SWH was announced, and fund-raising began. Despite opposition from the War Office, enough money was raised for the first two units to cross the Channel at the end of the year. Inglis left headquarters for good early in 1915 to work in the field, and went out with a unit to work in Serbia. She rapidly developed a deep affection for the Serbs which was to keep her in the country, working in conditions which were to worsen progressively as time passed. Typhus, dysentery and the weather were the women's greatest enemies: disease could be tackled by cleanliness and isolation, but the only defence against the Serbian winter was to wear three pairs of stockings, since skirts had to be cut short because ofthe mud. Food was scarce and hard to come by, and conditions were almost always appalling. On many occasions as the fighting progressed, the units had to evacuate their hospitals and set up at a distance elsewhere, often after a retreat in terrible weather.
A brief visit home at the end of 1915 was used by Inglis for more fund-raising, this time made easier by the fact that the returning 'Scottish heroines' found themselves celebrities. In August 1916 she led her next unit to Romania, where they tended Serb and Russian casualties. Leneman quotes a series of lively and rather critical passages from the letters of a medical student who was a member of this unit, which suggest that Elsie Inglis was at times rather more difficult and temperamentally unstable than had been apparent in the account up till that point. One explanation may have been that she was unwell before leaving England she had learned that she had cancer, and she appears to have been ill for much of her last year. By the autumn of 1917, when the unit was recalled back to England, Inglis was clearly terminally ill, and she died at the end of November, a few days after her ship docked at Newcastle. This little book documents the extraordinary life of an extraordinary woman, and Leah Leneman has done us a great service by gathering together the history of Elsie Inglis and the SWH before it was forgotten. This is an eclectic book, but none the worse for that. It provides an up-to-date review of the clinical and molecular genetics of several neuromuscular disorders, and its stated audience is all those involved in the management of patients or in research. Certainly, clinicians will find much of value and researchers will be interested in hearing of progress in areas adjacent to their own. Alan Emery is much respected and since retiring from his chair in genetics at Edinburgh seems to be more active than ever in his current position as research director of the European Neuromuscular Centre.
What is included and what is not? With respect to neurogenic disorders the areas covered include spinal muscular atrophy, familial amyotrophic lateral sclerosis, post-polio muscle dysfunction (an anomaly in view of the subtitle of the book), and hereditary neuropathies. Muscle disorders include the muscular dystrophies (dystrophinopathies, limb-girdle, congenital, Emery-Dreifuss, facio-scapulohumeral, oculopharyngeal), distal myopathies, mitochondrial myopathies, desminopathies, nemaline myopathy, myotubular myopathy, central core disease, fibrodysplasia ossificans progressiva, myotonic dystrophy, and muscle ion channelopathies. There is a chapter on congenital myasthenic syndromes. Omissions are few but include metabolic myopathies other than mitochondrial. Despite the extraordinary pace of change it is up to date and the publishers can be commended for their speed. Areas of development since publication include nemaline myopathy, oculopharyngeal muscular dystrophy and limb-girdle dystrophy (which is changing almost monthly). A total of 44 authors have contributed to the twenty-one chapters and they include a remarkably high proportion of the recognized leaders. Most chapters give some historical background, a summary of clinical features and, where appropriate, pathological details, but of course the main thrust is with respect to genetics, genes and molecular mechanisms. There are no poor chapters but some are exceptionally good. Clinicians will value particularly the chapters on facioscapulohumeral muscular dystrophy (Padberg), limb-girdle dystrophies (Beckman and Fardeau), myotonic dystrophy (Be Wieringa et a].) and hereditary neuropathies (Timmerman et a].). The congenital muscular dystrophies continue to cause nosological difficulties but the chapter by Tome et a]. provides an excellent introduction. Mitochondrial disorders remain much in vogue and are reviewed by Poulton. Goebel has made the field of desminopathies his own. Similarly, Riudel and Lehman-Horn are uniquely qualified to write on the muscle channelopathies.
Although up to date, it has to be said that this book will be out of date sooner than most. Despite that, I recommend it highly and for those people involved in neuromuscular disorders, whether clinicians or scientists, it will prove valuable for long enough to justify personal purchase. My copy is already well thumbed. David Hilton-Jones The teaching of junior doctors has always been an important part of a consultant's job. Until recently the apprenticeship model was felt to be satisfactory, with trainees learning by experience and from words of wisdom gleaned along the way. Now consultants are expected to provide structured training programmes, complete with appraisal, mentorship and support, for trainees at all levels. Reforms of junior doctors' training, introduced by the former Chief Medical
